Zinc is an extremely most abundant trace element in the brain. Substantial amounts of zinc exist in the presynaptic vesicles, and are released with glutamate during the neuronal excitation. Synaptically-released zinc is believed to play crucial roles in normal brain functions. Therefore, zinc deficiency impairs brain development and capabilities of learning and memory. Notwithstanding, recent studies have indicated that excess zinc is linked with several neurodegenerative diseases and has a causative role in delayed neuronal death after transient global ischemia. We have developed the sensitive assay system for zinc neurotoxicity in vitro using GT1-7 cells (immortalized hypothalamic neurons) to elucidate the functions of zinc in neurodegenerative diseases. Pharmacological experiments have exhibited the involvement of energy failure, metal-metal interaction, and disruption of calcium homeostasis in zincinduced neurotoxicity. It is inferred that zinc might play its part in brain functions as Janus, an ancient Roman god with two faces, and that zinc homeostasis is essential for the neuronal survival. Our assay system provides a good method for screening the protective substances of zinc neurotoxicity as a therapeutic target of the global ischemia.
INTRODUCTION
Zinc is the second most abundant transition metal in the body. It is essential for most living beings. The human body contains approximately 2 g of zinc.
It is mainly distributed in the blood, kidney, liver, bone, and brain. Zinc is a co-factor of more than 300 enzymes or metalloproteins. These zinc-related proteins play biologically important roles in mitotic cell division, protein synthesis, DNA and RNA synthesis etc. Therefore, zinc is essential for the normal growth and development. In 1961, Prasad et al. firstly reported that zinc deficiency caused the dwarfism with the retardation of physical and sexual development in human. 1) Nowadays, zinc deficiency is widely known to impair the overall immunological system, cause adverse effects of the body growth and the sexual development, and lead to olfactory and gustatory dysfunction. 2) A considerable amount of zinc is accumulated in the brain, particularly in the hippocampus, amygdala, cerebral cortex, and olfactory cortex. The total amount of zinc in the hippocampus is estimated as 70-90 ppm (dry weight). 3) Although some zinc in the brain firmly binds to metalloproteins or enzymes, a substantial amount of zinc (approximately 10% or more) forms free zinc ions (Zn 2+ ) or is loosely bound and detectable by the staining using chelating reagents. Chelatable zinc is stored in the presynaptic vesicles of particular excitatory neurons, and is secreted from vesicles to synaptic clefts with excitatory neurotransmitter glutamate during the neuronal excitation. 4) Its concentration is estimated to be approximately 300 µM.
5)
Despite its abundance, the physiological role of synaptically released zinc has not yet been defined precisely. It has been reported that zinc alters the behavior of various receptors or ion channels, including N-methyl-D-aspartate (NMDA)-type glutamate receptor, γ-aminobutyric acid A (GABAA) receptor, glycine receptor, acetylcholine receptor, ATP channel, voltage-gated Ca 2+ channel, and K + channel. 4) The most established effect of zinc is the modulation of postsynaptic excitability through inhibition of NMDA-type glutamate receptor. 6) A recent zinc-imaging study using newly developed zincsensitive fluorescent dye, ZnAF-2, demonstrated that zinc is released activity-dependently from the mossy fiber in the hippocampus, and that zinc modulates activity of neuronal circuits as a spatiotemporal mediator of neuronal signaling and synaptic plasticity. 7) Removal of that synaptic zinc by its chelator induced over-excitation in rat hippocampal neurons. 8) Moreover, synaptically released zinc is required for the induction of long-term potentiation (LTP). 9) These results indicate that zinc is essential for normal brain functions. Accordingly, zinc deficiency during maternal periods or in early developmental stages in human as well as in experimental animals severely damages brain development and impairs learning and memory abilities. 10) Furthermore, zinc deficiency influences learning ability and sensitivity of excitatory neurons in adult animals.
11)
Nonetheless, despite its importance, recent studies have revealed that excess zinc released in a pathological condition is toxic to the central nervous system and the relationship between zinc and neuronal death after traumatic brain ischemia has been specifically examined. Moreover, disruption of zinc homeostasis has been suggested to be implicated in several neurodegenerative diseases including Alzheimer's disease (AD), 12, 13) prion disease, 14) amyotrophic lateral sclerosis (ALS), 15) and Wilson's disease. 16) We review here the relationship between zinc neurotoxicity and neurodegenerative diseases and the significance of zinc homeostasis based on our studies and numerous other results.
ZINC AND ISCHEMIA
Interruption of blood flow after transient global ischemia induces delayed neuronal death, the development of an infarct, and subsequent cognitive dysfunction, which are believed to be based on pathogenesis of vascular dementia in elderly people. 17) In response to ischemia, an excitatory neurotransmitter -glutamate -is released from nerve terminals and accumulates in synaptic clefts. Excess glutamate causes over-stimulation of its receptors. Then, it induces the entry of large quantities of Ca 2+ to responding neurons through NMDA-type glutamate receptors or voltage-dependent Ca 2+ channels, and thereafter, the increased intracellular Ca 2+ triggers various pathways of apoptotic neuronal death. 18) As described above, zinc is co-released with glutamate to synaptic clefts by membrane depolarization in the ischemic condition. Choi and co-workers reported that zinc caused apoptotic death of primary cultured cortical neurons. 19) They also revealed the accumulation of chelatable zinc in degenerating neurons of the hippocampus after transient global ischemia. 20) This zinc translocation occurred in vulnerable neurons in the hippocampus after transient global ischemia but before the onset of the delayed neuronal death, and enhanced the infarct. 21) Administration of calcium EDTA (Ca-EDTA), a zinc-selective membrane-impermeable chelator, inhibited zinc-induced death of cultured cortical neurons, 20) blocked the accumulation of zinc, protected the hippocampal neurons after transient global ischemia, 22) and reduced the infarct volume. 21) These results firmly indicate zinc as a key factor in delayed neuronal death after the transient global ischemia which might be involved in the pathogenesis of vascular dementia. 23) However, its detailed mechanism is still under investigation.
ZINC AND AD
Mounting evidence has suggested the implication of zinc in the pathogenesis of AD. However, it remains still controversial. Although the precise etiology of AD is still not yet clear, it is widely believed that the abnormal deposition of β-amyloid protein (AβP), a major component of senile plaques, in the brain and its neurotoxicity may be based on the molecular mechanism of AD. 24) AβP is a 39-43 amino acid residue peptide derived from a large precursor protein amyloid precursor protein (APP). AβP has an intrinsic tendency to form insoluble aggregates with β-pleated sheet structures. Interestingly, the aggregation and the subsequent conformational change of AβP strongly correlate with its neurotoxicity. Therefore, factors which promote the aggregation of AβP may be involved in the pathogenesis of AD. Bush et al. found that zinc remarkably enhance the aggregation of AβP in vitro. 25) Zinc also binds to APP and modulates the binding of APP to extracellular matrix. 26) APP also binds to copper 27) and regulates copper homeostasis. 28) Furthermore, clioquinol, a copper/zinc-sensitive chelator, was reported to inhibit the accumulation of AβP in brains of experimental animals. 29) However, considering that zinc is abundantly present in the brain and that low concentration (micromolar level) of zinc is enough to initiate the aggregation of AβP, the adverse role of zinc in AD is still disputable. It is possible that zinc influences the homeostasis of other trace metals and contributes to the pathogenesis of AD, because other metals including aluminum, iron, and copper also accelerate the aggregation of AβP. 30) Meanwhile, the protective role of zinc in the pathogenesis of AD has been suggested. Aripe et al. found that AβP forms cationselective (including Ca 2+ ) ion channels on artificial lipid membranes. 31) We have revealed that AβP forms ion channels on neuronal cell membranes 13) and caused the abnormal increase of intracellular calcium level ([Ca 2+ ] i ).
32) Therefore, it is possible that channel-formation by AβP and the subsequent increase in [Ca 2+ ] i may trigger the apoptotic neurodegeneration and finally engenders the pathogenesis of AD. 33) Numerous studies demonstrate that zinc inhibits AβP-channel in lipid bilayer membranes as well as on membranes of neuronal cells. 13, 34, 35) Considering that both of zinc and APP coexists in synapses and secrets during neuronal excitation, it is provable that zinc may play as an endogenous blocker of AβP channel. It was also reported that zinc has concentration-dependent dual effects in AβP-neurotoxicity: low concentration of zinc protects neurons, but high concentration zinc enhance AβP-neurotoxicity. 36) Furthermore, there are several zinc-related metalloproteins related with AD. Uchida et al. found the protein termed the growth inhibitory factor (GIF) which has the ability of inhibiting the outgrowth of neuronal processes. GIF is abundantly present in the normal brain, however, remarkably depleted in the brain of AD patients. They studied the structure of GIF and found that GIF is metallothionein-III (MT-3) which binds to zinc and copper. 37) Zinc-binding to S100β, a calcium binding protein, influences its binding with hyperphosphorylated tau protein in AD patients. 38 ) Therefore, there is no doubt about the implication of zinc in the pathogenesis of AD, however, its role is complex and still controversial.
ZINC AND OTHER NEURODEGENERATIVE DISEASE
Prion disease is a transmissible amyloidogenic disease including Creutzfeldt-Jacob disease and Kuru disease in human, and bovine spongiform encephalopathy. The conversion of normal cellular form of prion protein (PrP C ) to the pathogenic protease-resistant form (PrP SC ) is believed to be based on the transmission and the pathogenesis of prion disease. Brown et al. reported that prion protein has the ability to bind to copper in vivo, and that PrPknockout mice exhibit the reductions in the copper content in the brain. 39) It is hypothesized that PrP C is a copper-metalloprotein and modulates copper homeostasis. As copper and zinc are competitive in the binding with metalloproteins, zinc also binds to the copper-binding domain of PrP C . Zinc as well as copper induces the endocytosis of PrP C , 40) and causes the aggregation of PrP fragment peptide (PrP106-126) and enhances its neurotoxicity. 41) Considering that zinc concentration in the brain is much higher than that of copper, zinc might contribute the functions of PrP C . In 1994, linkage analysis of gene of familial ALS patients demonstrated that mutations in the gene of copper, zinc superoxide dismutase (Cu, Zn-SOD) was responsible for the disease. 42) Cu, Zn-SOD is a primary antioxidant enzyme which enables to regulate superoxide. The link between zinc and other neurodegenerative diseases should not be disregarded.
ZINC NEUROTOXICITY IN VITRO
We have investigated the mechanism of zincinduced neurotoxicity in vitro to define the role of zinc in ischemic neuronal injury. [43] [44] [45] [46] [47] Characterization of zinc neurotoxicity to cultured neuronal cells has been investigated mainly using primary cultured neurons of the rat cerebral cortex 19) or PC-12 cells.
48)
However, we found that GT1-7 cells (immortalized hypothalamic neurons) are much more sensitive to zinc than are other neuronal cells. 43, 44) The GT1-7 cells were developed by Mellon et al. by genetically targeting tumorigenesis of mouse hypothalamic neurons.
49) The cells possess neuronal characteristics such as the extension of neuritis, the secretion of gonadotropin-releasing hormone (GnRH), and the expression of neuron-specific proteins or receptors including microtubule-associated protein 2 (MAP2), tau protein, neurofilament, synaptophysine, GABAA receptor, glutamate receptor, dopamine receptor, and L-type Ca 2+ channels. These properties imply that the GT1-7 cell line is a good tool for investigation of neuroendocrine systems 50) or of AD. 32, 51) We compared the viability of GT1-7 cells, PC-12 cells, B-50 cells (neuroblastoma cell line), primary cultured neurons of rat cerebral cortex, and primary cultured neurons of rat hippocampus after the exposure to zinc (Fig. 1) . 44) Among these neuronal cells, GT1-7 cells exhibited the lowest viability after zinc exposure. Zinc caused death of GT1-7 cells in a dosedependent and time-dependent manner ( Fig. 2A) . 43 ) Figure 2B shows phase-contrast images of GT1-7 cells that had been stained with trypan-blue both with and without exposure to zinc. Degenerated GT1-7 cells after zinc exposure exhibit retraction of neuritic processes and cell body shrinkage. These degenerated cells were also terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) positive and exhibited apoptotic properties. 43 ) Therefore, we have used the GT1-7 cell line as an excellent model system for investigation of zinc neurotoxicity
MECHANISM OF ZINC-INDUCED NEUROTOXICITY
To elucidate the molecular pathways involved in zinc-induced death of GT1-7 cells, we preadministered various pharmacological compounds and observed changes in viability after zinc exposure. Among tested compounds including agonists or antagonists of neurotransmitters, channel blockers, etc., we found that the administration of sodium pyruvate significantly inhibited zinc-induced death of GT1-7 cells. 43) Shelline et al. reported that zinc inhibited glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and that pyruvate, an energy substrate, attenuated zinc-induced death of cultured cortical neurons. 52) Therefore, it is possible that the energy failure and the inhibition of glycolysis are based on the mechanism of zinc neurotoxicity also in GT1-7 cells. However, agonists or antagonists of excitatory neurotransimitters [2-amino-5-phosphonovaleric acid (D-APV), glutamate, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX)], or those of inhibitory neurotransmitters (bicuculline, muscimol, baclofen, GABA) did not attenuate the viability of GT1-7 cells after zinc exposure. [43] [44] [45] [46] [47] These findings are inconsistent with previous findings about the involvement of NMDA type glutamate receptor 19) or alpha-amino-3-hydroxy-5-methyl-4-isoxazole propinic acid (AMPA) type glutamate receptor 53, 54) in zinc neurotoxicity in cultured cortical neurons. However, Mahesh demonstrated that the GT1-7 cells lack or possess low levels of ionotropic glutamate receptor and did not exhibit glutamate toxicity. 55) These evidences confirmed that the distinct mechanism of zinc neurotoxicity, which is not mediated by glutamate receptor, might be dominant in GT1-7 cells.
ZINC NEUROTOXICITY AND METAL-METAL INTERACTION
Functions of trace metals are known to be influenced greatly by other metals because many metalbinding proteins share the ability of binding other No. 1 pocampal neurons after global ischemia. 20, 22) Lee et al. reported that intracerebral administration of pyruvate blocked the zinc accumulation as well as the degeneration of hippocampal neurons after ischemia.
57) The GT1-7 cells, which are highly vulnerable to zinc, provide a sensitive assay system for screening such substances. We examined inhibitory effects of various agricultural products on zinc-induced death of GT1-7 cells, and found that the water-soluble extract of mango, Mangifera indica L., a subtropical fruit, significantly blocked zinc neurotoxicity. 58) Inhibition was not related with anti-oxidant activity of mango extract. Although we are now determining the structure of the responsive substance, it may become the seed of a new drug for ischemia.
CONCLUSION
Considering these evidences, we have made a hypothetical scheme for zinc neurotoxicity (Fig. 4) . In the normal condition, zinc regulates the postsynaptic excitability by the binding to NMDA type glutamate receptor and attenuates AβP neurotoxicity by blocking AβP channel. Altogether, zinc plays protective role for the overexcitation or AβP neurotoxicity. However, in pathological conditions such as ischemia, excess zinc is released in the synaptic cleft with glutamate. Zinc is translocated through the AMPA-dependent Ca 2+ channel 54) or through other pathways into the target neuron, where zinc inhibits various enzymes, influences mitochondria respiration, 59 ) and causes energy depletion 52) in the neuron. Excess glutamate induces elevation of intracellular Ca 2+ level of the target neuron. Zinc also causes the increase in intracellular Ca 2+ levels and enhances effects of glutamate. The elevated levels of intracellular Ca 2+ trigger various apoptotic pathways such as the activation of calpain, the activation of caspases or other enzymatic pathways related to apoptosis, and finally engenders to neuronal death.
Mounting evidence indicate that zinc depletion and excess zinc cause severe damage in neurons and learning disorders and that the disruption of zinc homeostasis might engender to several neurodegenerative disorders. However, the role of zinc is still undefined. Zinc might play a role like that of Janus, an ancient Roman god of doorways with two different faces, in the brain. Our developed system using GT1-7 cells will provide a useful tool to define its role in the brain. Further research about the role of After 24 hr, the viability was measured using the WST-1 method. For the compensation of endogenous toxicity of the metal, the difference was calculated between the viability of the metal alone and viability of zinc and metal, and described as the relative viability. Data are means +/-S.E.M., n = 6. *p < 0.01. metals to a greater or less degree. For example, zinc influences copper homeostasis in Wilson's disease. 16) Iron supplementation influences zinc absorption and vice versa. 56) We observed the viability of GT1-7 cells with or without various metal ions after exposure to zinc (Fig. 3) , 46, 47) 48) Administration of L-type Ca 2+ channel blocker attenuated zinc-induced death of GT1-7 cells (data not shown here). Therefore, it is highly possible that dyshomeostasis of calcium might be involved in the mechanism of zinc neurotoxicity.
SCREENING FOR PROTECTIVE SUBSTANCES OF ZINC NEUROTOXICITY
The implication of zinc in transient global ischemia suggests that substances that inhibit zinc neurotoxicity might be candidates for drugs for prevention or treatment of brain ischemia. As noted, zinc chelators were effective in the protection of hip-zinc and its toxicity might engender the development of new treatment for neurodegenerative diseases.
Fig. 4. Hypothetical Scheme of Zinc Neurotoxicity
Zinc (Zn) coexists with glutamate (Glu) in presynaptic vesicles and is secreted with neuronal excitation. In normal conditions, secreted zinc binds to NMDA type glutamate receptor (NMDA-R) and modulates postsynaptic excitability. AβP, which also secreted in synaptic clefts, aggregates and forms channel on membranes. Zinc binds to AβP channel and inhibits Ca 2+ influx through the channel. Therefore, zinc plays a protective role. However, in the pathological conditions such as ischemia, great amounts of zinc are released in synaptic clefts and translocated into postsynaptic target neurons through AMPA-type glutamate receptor (AMPA-R)-related Ca 2+ channel or other pathways such as voltage-dependent L-type Ca 2+ channel (VDLC). That zinc then inhibits numerous enzymes including mitochondria respiratory enzymes and causes energy depletion. Furthermore, zinc increases intracellular Ca 2+ levels and enhances effects of glutamate. Increased Ca 2+ triggers various apoptotic pathways including the activation of calpain, etc. Dyshomeostasis of zinc and calcium eventually engenders delayed neuronal death after transient global ischemia.
